ACLS Acute Coronary Syndrome Algorithm

1. Patient Assessment and ACS Recognition

Healthcare providers must rapidly identify acute coronary syndrome through systematic evaluation. Common symptoms of ACS are chest pain, pressure, diaphoresis, nausea, and shortness of breath. The assessment also includes vital signs and a focused physical examination. Healthcare providers should also obtain a 12-lead electrocardiogram within 10 minutes of arrival. Medical history evaluation covers previous cardiac events, medications, allergies, and risk factors.

2. Immediate Treatment

Initiate treatment protocols hand in hand with ongoing assessment. Start to provide oxygen therapy to patients with saturation below 90% or who are respiratory distressed. Standard practice avoids routine oxygen administration in patients with normal saturation levels. If no contraindications exist, give 160-325 mg aspirin (preferably chewable). Also, provide sublingual nitroglycerin 0.4 mg for persistent chest discomfort when the patient remains hemodynamically stable. Finally, verify systolic pressure stays above 90 mmHg before giving medication.

3. Establishing a Diagnosis

Continue diagnostic evaluation while monitoring patient stability. Also, obtain cardiac biomarkers, including troponin levels, blood count, and coagulation studies. Complete chest X-ray within 30 minutes to assess for complications. ECG interpretation also helps determine the appropriate treatment pathway. ST-segment elevation indicates STEMI requiring immediate reperfusion therapy. While non-ST-segment elevation ACS indicates NSTEMI and unstable angina. Furthermore, serial ECG monitoring detects evolving changes not apparent on initial assessment. Continuous cardiac monitoring identifies new arrhythmias or progressive ischemic changes that may alter treatment decisions.

4. Reperfusion and Advanced Care

For STEMI

Primary PCI is the go-to reperfusion method for STEMI when available within 90 minutes of first medical contact. When PCI is unavailable or delayed, fibrinolytic therapy should be used. Teams should aim for door-to-balloon times under 90 minutes and door-to-needle times under 30 minutes for fibrinolysis. Along with reperfusion, patients should receive dual antiplatelet therapy combining aspirin with P2Y12 inhibitors, anticoagulation using heparin, and beta-blockers unless contraindicated.

For NSTEMI/Unstable Angina

High-risk patients showing refractory chest pain, unstable blood pressure, dangerous heart rhythms, or ongoing ST-segment changes benefit from early invasive strategies. Stable patients without these warning signs can often be managed medically first. Standard treatment includes dual antiplatelet therapy, blood thinners, beta-blockers, ACE inhibitors, and cholesterol medications. Continuous heart monitoring helps clinicians decide when to escalate treatment based on how patients respond and their overall risk profile.

5. Ongoing Monitoring and Support

Continuous cardiac monitoring tracks rhythm changes, ischemic episodes, and treatment response. Also, monitor vital signs, oxygen saturation, and neurological status regularly. Assess for complications, including heart failure, arrhythmias, or bleeding from anticoagulation therapy. Additionally, provide patient education on medication adherence, lifestyle modifications, and warning signs.